CDTX vs IR · rev $1.3M vs P/E 49, rev $7.24B
Cidara Therapeutics Inc (CDTX) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
CDTX currently screens at market cap $6.96B. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the CDTX and IR stock pages for the full models.
Not investment advice.